Back

Cardiovascular risk following cannabinoid treatment for patients with chronic pain

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Drug cardiotoxicity: what do we need to know? Cardiotoxicity of Drugs ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Miss Nina Nouhravesh

Duke Clinical Research Institute, Durham (United States of America)

6 More presentations in this session

Presentation thumbnail
Berberine associated to SGLT2i Dapagliflozin synergistically reduces cardiac cell apoptosis during exposure to Trastuzumab through reduction of AGEs and IL-6 and induction of pAMPK
Doctor N. Maurea (Naples, IT)
Abstract Slides
Presentation thumbnail
Dose-dependency of diclofenac's cardiovascular risks: a series of nationwide emulated trials
Associate Professor M. Schmidt (Aarhus, DK)
Abstract Slides
Presentation thumbnail
Pembrolizumab, Ipilimumab and Nivolumab reduces cardiac pAMPK and IL-10, increases vascular NF-kB expression and levels of IL-1b, IL-2 and IL-6 in myocardial tissue
Doctor N. Maurea (Naples, IT)
Abstract Slides
Presentation thumbnail
Incidence of drug-drug interactions of QT-prolonging drugs in an onco-hematological outpatient
Mr E. Fort (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Sacubitril-valsartan activates pAMPK and reduces NLRP3, MyD88, cytokines/growth factors and DAMPs in doxorubicin-treated mice improving longitudinal strain and ejection fraction
Doctor N. Maurea (Naples, IT)
Abstract Slides

Access the full session

Session thumbnail
Drug cardiotoxicity: what do we need to know?

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Can we accurately predict cardiovascular complications in targeted cancer therapies?
thumbnail
Webinar
Multidisciplinary strategies for monitoring and managing cardiovascular toxicity in patients with cancer
thumbnail
Congress Presentation
Treatment options for cancer therapy-related cardiac dysfunction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources